Double-Blind, Randomized, Placebo-Controlled, Phase 2 Safety And Efficacy Trial Of Multistem In Adults With Ischemic Stroke

Trial Profile

Double-Blind, Randomized, Placebo-Controlled, Phase 2 Safety And Efficacy Trial Of Multistem In Adults With Ischemic Stroke

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Allogeneic stem cell therapy Athersys (Primary)
  • Indications Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MASTERS-1
  • Sponsors Athersys
  • Most Recent Events

    • 20 Mar 2017 According to an Athersys media release, results from this study were published in the peer-reviewed journal, The Lancet Neurology.
    • 12 Sep 2016 Results (n=126) published in an Athersys media release.
    • 19 Feb 2016 Exploratory results (n=126) presented at the 41st International Stroke Conference
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top